[{"id":"2fbf63a3-c5d3-4871-867d-819c244d5d8f","acronym":"","url":"https://clinicaltrials.gov/study/NCT02685592","created_at":"2021-01-18T13:05:56.005Z","updated_at":"2024-07-02T16:37:10.399Z","phase":"Phase 4","brief_title":"Photodynamic Therapy for Lentigo Maligna Using 5-aminolevulinic Acid Nanoemulsion as a Light Sensitizing Cream","source_id_and_acronym":"NCT02685592","lead_sponsor":"Joint Authority for Päijät-Häme Social and Health Care","biomarkers":" TERT • MITF","pipe":" | ","alterations":" TERT mutation","tags":["TERT • MITF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TERT mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Ameluz (aminolevulinic acid)"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 02/01/2016","start_date":" 02/01/2016","primary_txt":" Primary completion: 03/01/2018","primary_completion_date":" 03/01/2018","study_txt":" Completion: 03/01/2018","study_completion_date":" 03/01/2018","last_update_posted":"2018-05-30"},{"id":"ac2198c6-82dc-4dc5-9ae4-52b876976d62","acronym":"","url":"https://clinicaltrials.gov/study/NCT01065467","created_at":"2021-01-18T04:11:55.440Z","updated_at":"2025-02-25T15:50:52.615Z","phase":"Phase 1","brief_title":"Panobinostat (LBH589) in Patients With Metastatic Melanoma","source_id_and_acronym":"NCT01065467","lead_sponsor":"Dana-Farber Cancer Institute","biomarkers":" MITF","pipe":"","alterations":" ","tags":["MITF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Farydak (panobinostat)"],"overall_status":"Completed","enrollment":" Enrollment 16","initiation":"Initiation: 02/01/2010","start_date":" 02/01/2010","primary_txt":" Primary completion: 03/01/2013","primary_completion_date":" 03/01/2013","study_txt":" Completion: 03/13/2017","study_completion_date":" 03/13/2017","last_update_posted":"2017-03-28"}]